Buscar resultados de ensayos clínicos
Carcinoma, Endometrioid - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer Condición:
|
Recruiting |
Nombre del estudio: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
Recruiting |
Nombre del estudio: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición:
|
Recruiting |
Nombre del estudio: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
Completed |
Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Condición:
|
Recruiting |
Nombre del estudio: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condición:
|